Nesreen S Ismail

3PUBLICATIONS
17CO-AUTHORS
TransgenesisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 13, 2026
WTX-124, a Conditionally Activated Wild-Type IL2, Maximizes the Therapeutic Index of IL2, Unlike "Non-Alpha" Muteins.

Christopher J Nirschl, Kulandayan K Subramanian, Heather R Brodkin

|Apr 19, 2023
mWTX-330, an IL-12 INDUKINE Molecule, Activates and Reshapes Tumor-Infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity.

Christopher J Nirschl, Heather R Brodkin, Celesztina Domonkos

|Mar 14, 2022
Discovery of a Conditionally Activated IL-2 that Promotes Antitumor Immunity and Induces Tumor Regression.

Christopher J Nirschl, Heather R Brodkin, Daniel J Hicklin

Pageof 1